Panelists discuss how novel intravitreal agents faricimab and high-dose aflibercept 8mg offer potential advantages in treating retinal diseases through their extended durability and dual mechanism of action.
Dr Zeba A. Syed emphasises the importance of performing surgery sooner rather than later for patients with Pseudomonas scleritis
A new device for goniotomy has the advantage of an irrigation/aspiration system, which offers easier excision of the trabecular meshwork and better visibility. Dr Desai shares his experiences using the device as well as his tips and surgical pearls for success.
Dr Ramin Tadayoni discusses the myopia panel at the EURETINA 2021 virtual meeting.
Newly developed acrylic implant provides option for patients with endothelial dysfunction.
An AI-supported telemedicine effort from Siloam Vision and Orbis International
For ophthalmologists, finding the ideal solution for presbyopia has long been the ‘holy grail’ of the field.
Patients who received digital education demonstrated a better understanding of their disease and its management
Two randomised controlled trials, EMGT and UKGTS, have examined the factors affecting the risk of glaucoma progression. Global target IOPs are not the best option for all patients.
Computer software platform provides home vision exercises to overcome asthenopia.
New analysis brings disease progression and therapeutics into focus
In visual field progression results, SLT was superior to ocular drops as first-line treatment for patients with glaucoma
Diabetic Retinopathy ranked as the fifth most common cause of blindness among adults aged 50 and older in 2020 according to data from the Global Burden of Disease study. Aude Couturier, MD shares her experience of using advanced imaging technologies to optimize diagnosis and surgical management of her DR patients in our latest Case of the Month.
In response to a previously published article, three ophthalmologists present their views on intravitreal pharmacotherapy injections.
Lenticule Extraction for treating patients with hyperopia is now available with SMILE® pro, performed on the VISUMAX® 800 from ZEISS. This additional option provides a valuable corneal-based alternative for younger patients without cataract. In this Case of the Month, you will discover the advantages of this procedure and review the outcomes of a 30-year-old patient who chose to undergo Lenticule Extraction with ZEISS SMILE pro after experiencing discomfort with contact lenses for many years.
Recent reports of retinal atrophy have raised concerns on potential long-term safety.
Detecting mitochondrial dysfunction may give clinicians a chance to reduce the rate of cognitive decline in patients with dementia
Quantitative and qualitative improvement in IOL design
A short course of a low-dose corticosteroid eye drop can relieve inflammation with only a low increase in intraocular pressure.
The case for treating keratoconus without waiting for disease progression
Gildeuretinol halts Stargardt disease progression, study results indicate
Sequential customised therapeutic keratectomy (SCTK) improves visual quality by eliminating superficial corneal high order aberrations
Foundation Fighting Blindness is a driving force in advancing retinal gene therapies into clinical trials.
Diabetes mellitus, which is a common chronic disease in children, can lead to significant eye morbidities with long-lasting effects, including diabetic retinopathy. Treatment should be tailored to the individual patient.
Landmark randomised controlled trials have advanced the understanding and treatment of glaucoma.
Increasing understanding of the genetics behind Usher syndrome suggests that treatment may become possible in the very near future.
A global survey of retinal experts assessed their perceptions of evolving clinical practice in the Covid-19 era, focusing on digital teleophthalmology, home monitoring and decentralised patient care.